• DOI:10.1016/j.therap.2017.03.003
Corpus ID: 46834384

Success of tardive electroconvulsive therapy sessions after loxapine-induced malignant syndrome in the context of very poor metabolisation.

@article{Descoeur2017SuccessOT,
  title={Success of tardive electroconvulsive therapy sessions after loxapine-induced malignant syndrome in the context of very poor metabolisation.},
  author={J. Descoeur and L. Philibert and K. Chalard and J. Attal and P. Petit and K. Klouche and M. Olivier},
  journal={Therapie},
  year={2017},
  volume={72 6},
  pages={
          643-647
        }
}

J. Descoeur, L. Philibert, +4 authors M. Olivier

Published 2017

Medicine

Therapie

We report the success of tardive electroconvulsive therapy in a case of loxapine malignant syndrome with catatonia. Loxapine and its metabolites were measured in biological samples by liquid chromatography coupled to tandem mass spectrometry. Genes were studied by sequencing and quantitative polymerase chain reaction (PCR). Plasmatic drug concentrations showed a supratherapeutic concentration of loxapine with a very low 8-hydroxyloxapine/loxapine ratio (range from 0.32 to 0.66, normal value>2… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed